Table 5:
A breakdown of datasets used in this study
| Dataset | Brief description | IFN system | ISGs | Non-ISGs | ELGs | Usage |
|---|---|---|---|---|---|---|
| S1 | Background human genes | IFN-α in fibroblast cells | 1,315 | 7,304 | 2,217 | Analyses |
| S2 | Dataset with high confidence | IFN-α in fibroblast cells | 620 | 874 | 0 | Analyses |
| S2′ | Training subset of S2 | IFN-α in fibroblast cells | 496 | 496 | 0 | Training |
| S2′′ | Testing subset of S2 | IFN-α in fibroblast cells | 124 | 378 | 0 | Testing |
| S3 | ISGs with low confidence in S1 | IFN-α in fibroblast cells | 695 | 0 | 0 | Testing |
| S4 | IRGs divided from S1 | IFN-α in fibroblast cells | 0 | 1,006 | 0 | Analyses/testing |
| S5 | ISGs from Interferome [24] | Type I IFNs in all cells | 1,259 | 872 | 0 | Testing |
| S6 | ISGs from Interferome [24] | Type II IFN in all cells | 2,229 | 755 | 0 | Testing |
| S7 | ISGs from Interferome [24] | Type III IFN in all cells | 33 | 1,683 | 0 | Testing |
| S8 | ELGs divided from S1 | IFN-α in fibroblast cells | 0 | 0 | 2,217 | Testing |